• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基础代谢率影响肝细胞癌的发生和发展。

Basal metabolic rate shapes the development and progression of hepatocellular carcinoma.

作者信息

Maciak Sebastian, Sawicka Diana, Kasacka Irena, Chyczewski Lech, Car Halina, Konarzewski Marek

机构信息

Department of Evolutionary and Physiological Ecology, University of Bialystok, K. Ciolkowskiego 1J, Bialystok, 15-245, Poland.

Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, 15-295, Poland.

出版信息

BMC Cancer. 2025 Jul 1;25(1):1102. doi: 10.1186/s12885-025-14491-4.

DOI:10.1186/s12885-025-14491-4
PMID:40598035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12210623/
Abstract

BACKGROUND

Among several cancer risk factors, the variation in basal metabolism rate (BMR), which constitutes up to 70% of total energy expenditures in humans, may be causally linked with neoplasm development. As BMR reflects the mass of metabolically active organs, being the function of cell size and/or cell number, it may serve as a critical metabolic proxy of cancer susceptibility in the context of cell growth and cell size.

METHODS

We examined the progression and rate of development of chemically induced hepatocellular carcinoma, using lines of mice divergently selected for high or low BMR and differing with respect to both the size of metabolically active organs and their cellular architecture.

RESULTS

The high BMR mouse line developed hepatocellular carcinoma much faster and with a higher progression rate, accompanied by a considerable increase in liver size and hepatocyte enlargement, as compared to the low BMR mouse line. The HBMR mice also manifested an increased expression of metabolism- and cell size-related genes (mTOR, PI3K, c-myc, but not IGF-1), with a simultaneous decrease in the activity of tumor suppressors (p-53, APC) at the beginning of cancerogenic processes, promoting further neoplasm expansion.  CONCLUSION: Presented results suggest that genetically determined high BMR may additionally burden liver cells via changes in the action of specific genes, leading to higher tumorigenesis.

摘要

背景

在多种癌症风险因素中,基础代谢率(BMR)的变化可能与肿瘤发生存在因果联系,基础代谢率在人类总能量消耗中占比高达70%。由于基础代谢率反映了代谢活跃器官的质量,而这是细胞大小和/或细胞数量的函数,在细胞生长和细胞大小的背景下,它可能作为癌症易感性的关键代谢指标。

方法

我们使用为高基础代谢率或低基础代谢率而进行 divergent 选择的小鼠品系,这些品系在代谢活跃器官的大小及其细胞结构方面存在差异,研究化学诱导的肝细胞癌的进展和发展速度。

结果

与低基础代谢率小鼠品系相比,高基础代谢率小鼠品系肝细胞癌发展得更快且进展率更高,同时肝脏大小显著增加且肝细胞增大。高基础代谢率小鼠在致癌过程开始时还表现出与代谢和细胞大小相关基因(mTOR、PI3K、c-myc,但不包括IGF-1)的表达增加,同时肿瘤抑制因子(p-53、APC)的活性降低,从而促进肿瘤进一步扩大。

结论

呈现的结果表明,遗传决定的高基础代谢率可能通过特定基因作用的改变额外加重肝细胞负担,导致更高的肿瘤发生风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/ac3de5885fc7/12885_2025_14491_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/dadafacfccb9/12885_2025_14491_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/1ca82b276079/12885_2025_14491_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/c5a0822dc086/12885_2025_14491_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/ac3de5885fc7/12885_2025_14491_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/dadafacfccb9/12885_2025_14491_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/1ca82b276079/12885_2025_14491_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/c5a0822dc086/12885_2025_14491_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0894/12210623/ac3de5885fc7/12885_2025_14491_Fig4_HTML.jpg

相似文献

1
Basal metabolic rate shapes the development and progression of hepatocellular carcinoma.基础代谢率影响肝细胞癌的发生和发展。
BMC Cancer. 2025 Jul 1;25(1):1102. doi: 10.1186/s12885-025-14491-4.
2
External beam radiotherapy for unresectable hepatocellular carcinoma.不可切除肝细胞癌的外照射放疗
Cochrane Database Syst Rev. 2017 Mar 7;3(3):CD011314. doi: 10.1002/14651858.CD011314.pub2.
3
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
4
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
5
Exploring the mechanism of Naringenin in the treatment of hepatocellular carcinoma based on mRNA sequencing and experimental validation.基于mRNA测序和实验验证探索柚皮素治疗肝细胞癌的机制
Sci Rep. 2025 Jul 2;15(1):23109. doi: 10.1038/s41598-025-09013-y.
6
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
7
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
8
RPL35A Downregulation Suppresses Hepatocellular Carcinoma Cell Proliferation via NCAPG2 Inactivation.RPL35A下调通过NCAPG2失活抑制肝癌细胞增殖。
Cancer Med. 2025 Jun;14(12):e70985. doi: 10.1002/cam4.70985.
9
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
10
Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.中期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD011649. doi: 10.1002/14651858.CD011649.pub2.

本文引用的文献

1
Lactation at hot temperature: a test of heat dissipation limitation in mice divergently selected for basal metabolic rate.高温环境下的泌乳:对基础代谢率进行差异选择的小鼠散热限制的一项测试
Biol Lett. 2025 Jun;21(6):20250048. doi: 10.1098/rsbl.2025.0048. Epub 2025 Jun 4.
2
Metabolic Rate and Oxidative Stress as a Risk Factors in the Development of Colorectal Cancer.代谢率和氧化应激作为结直肠癌发展的危险因素。
Int J Mol Sci. 2024 Oct 5;25(19):10713. doi: 10.3390/ijms251910713.
3
Deep learning infers clinically relevant protein levels and drug response in breast cancer from unannotated pathology images.
深度学习从未标注的病理图像中推断出乳腺癌中临床相关的蛋白质水平和药物反应。
NPJ Breast Cancer. 2024 Feb 27;10(1):18. doi: 10.1038/s41523-024-00620-y.
4
Differences in the range of thermoneutral zone between mouse strains: potential effects on translational research.不同品系小鼠的体温舒适区范围存在差异:对转化研究的潜在影响。
Am J Physiol Regul Integr Comp Physiol. 2024 Feb 1;326(2):R91-R99. doi: 10.1152/ajpregu.00154.2023. Epub 2023 Nov 27.
5
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.mTOR(哺乳动物雷帕霉素靶蛋白)信号通路在人类健康和疾病中的多方面作用。
Signal Transduct Target Ther. 2023 Oct 2;8(1):375. doi: 10.1038/s41392-023-01608-z.
6
Prognostic significance of mutation in hepatocellular carcinoma: a systematic review and meta-analysis.肝细胞癌中突变的预后意义:一项系统评价和荟萃分析
Aging (Albany NY). 2023 Sep 20;15(18):9759-9778. doi: 10.18632/aging.205047.
7
Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma.靶向肝细胞癌中的表皮生长因子受体/磷脂酰肌醇-3激酶/蛋白激酶B/雷帕霉素靶蛋白信号通路
Pharmaceutics. 2023 Aug 14;15(8):2130. doi: 10.3390/pharmaceutics15082130.
8
p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma.p53表达与肝细胞癌患者的肿瘤分期、分级及亚型相关。
Mol Clin Oncol. 2023 May 24;19(1):54. doi: 10.3892/mco.2023.2650. eCollection 2023 Jul.
9
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.p53抑制在肝细胞癌发病机制中的作用。
World J Gastrointest Pathophysiol. 2023 Jun 1;14(3):46-70. doi: 10.4291/wjgp.v14.i3.46.
10
Total daily energy expenditure has declined over the past three decades due to declining basal expenditure, not reduced activity expenditure.由于基础代谢消耗减少,而不是活动消耗减少,过去三十年来,总能量消耗一直在下降。
Nat Metab. 2023 Apr;5(4):579-588. doi: 10.1038/s42255-023-00782-2. Epub 2023 Apr 26.